The CARRA Registry will help monitor the long term safety of current medications being used to treat pediatric rheumatic diseases. By collecting information from thousands of patients to evaluate their treatments, side effects and quality of life.
Children and young adults with pediatric rheumatic disease from 2 to 21 years of age.
Patients over 21 years of age.
Duke University
Sherry Hillyer, Clinical Research Nurse: 330-543-5853
Jessica Kracker, Clinical Research Nurse: 330-543-0846
Interim Director, Division of Rheumatology; Pediatric Rheumatologist
Pediatric RheumatologyVasculitis Clinic